Clinical Trials Logo

Refractive Errors clinical trials

View clinical trials related to Refractive Errors.

Filter by:

NCT ID: NCT06044688 Not yet recruiting - Astigmatism Clinical Trials

EyeQue VisionCheck 510(k) Clinical Trial

Start date: October 2023
Phase: N/A
Study type: Interventional

Demonstrate that refraction measurements from the device agree with refraction measurements from a phoropter within clinically meaningful limits.

NCT ID: NCT06021353 Recruiting - Refractive Errors Clinical Trials

Contralateral Study of WaveLight® Femtosecond Laser Devices for Corneal Flap Creation

Start date: October 20, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the WaveLight Ultraviolet Femtosecond Laser System, Model 1026 (UV fs-Laser) corneal flap creation accuracy as compared to the already marketed WaveLight FS200 Infrared Femtosecond Laser, Model 1025 (IR fs-Laser).

NCT ID: NCT05992675 Enrolling by invitation - Refractive Errors Clinical Trials

Air Optix® Night and Day® Aqua Continuous Wear

Start date: October 5, 2023
Phase:
Study type: Observational

The purpose of this retrospective, Post-Market Clinical Follow-Up (PMCF) study is to assess the long term performance and safety of Air Optix® Night and Day® Aqua (AONDA) contact lenses in a real-world setting when worn as 30 days of continuous wear for vision correction.

NCT ID: NCT05976750 Enrolling by invitation - Myopia Clinical Trials

Air Optix® Night and Day® Aqua Daily Wear

Start date: October 3, 2023
Phase:
Study type: Observational

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix® Night and Day® Aqua (AONDA) contact lenses in a real-world setting when worn as daily wear for vision correction.

NCT ID: NCT05964634 Not yet recruiting - Myopia Clinical Trials

Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia

Start date: August 1, 2023
Phase:
Study type: Observational

This study intends to analyze the characteristics between peripapillary retinal nerve fiber layer thickness and peripapillary area in high myopia with or without glaucoma

NCT ID: NCT05959200 Completed - Myopia Clinical Trials

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses

Start date: August 14, 2023
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.

NCT ID: NCT05957458 Completed - Myopia Clinical Trials

Myopia Control With Three Lever Irradiance of PBM Therapy in Children and Adults

MCPT
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Photobiomodulation therapy, that is, Low-level red-light technology provides a new and innovative myopia control approach. This strategy enables relatively high energies of light to be delivered at much shorter durations of exposure to induce the myopia control effect. The efficacy of the low-level red-light technology has been proven in a Chinese populationb for the recent 3 years with evidence based papers and amazing results. However, there's not yet evidence to demonstrate the relationship between the dose response effect of photobiomodulation therapy on myopia control at the different age lever.

NCT ID: NCT05936489 Completed - Presbyopia Clinical Trials

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Start date: July 6, 2023
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, randomized study to assess the plasma pharmacokinetic profile of LNZ101 and LNZ100.

NCT ID: NCT05927753 Completed - Clinical trials for Refractive Error - Myopia Bilateral

Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens

Start date: June 8, 2023
Phase: N/A
Study type: Interventional

This clinical study is to provide clinical performance data comparing the test lens (Deseyne [vifilcon C] daily disposable soft contact lens) to a control lens (1-Day Acuvue Moist [etafilcon A] daily disposable soft contact lens) in the same indication for use (single use prior to removal followed by a fresh lens upon the next lens wear exposure). The study is designed to test the hypothesis that the test lens is substantially equivalent to the control lens in like indications for use.

NCT ID: NCT05886894 Enrolling by invitation - Refractive Errors Clinical Trials

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Start date: August 8, 2023
Phase:
Study type: Observational

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.